Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1956 1
1959 7
1960 3
1961 1
1962 4
1963 4
1964 3
1965 7
1966 3
1967 3
1968 8
1969 3
1970 3
1971 1
1972 5
1973 9
1974 10
1975 10
1976 10
1977 10
1978 11
1979 11
1980 24
1981 34
1982 29
1983 25
1984 33
1985 42
1986 52
1987 64
1988 73
1989 78
1990 74
1991 86
1992 114
1993 120
1994 166
1995 173
1996 179
1997 226
1998 229
1999 303
2000 356
2001 425
2002 501
2003 649
2004 781
2005 1021
2006 1238
2007 1362
2008 1578
2009 1913
2010 2137
2011 2539
2012 2958
2013 3572
2014 4005
2015 4509
2016 4799
2017 5353
2018 6003
2019 7118
2020 8238
2021 9543
2022 11178
2023 10964
2024 12316
2025 3587

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

98,983 results

Results by year

Filters applied: . Clear all
Page 1
Causality-enriched epigenetic age uncouples damage and adaptation.
Ying K, Liu H, Tarkhov AE, Sadler MC, Lu AT, Moqri M, Horvath S, Kutalik Z, Shen X, Gladyshev VN. Ying K, et al. Among authors: liu h. Nat Aging. 2024 Feb;4(2):231-246. doi: 10.1038/s43587-023-00557-0. Epub 2024 Jan 19. Nat Aging. 2024. PMID: 38243142 Free PMC article.
Pyrotinib versus placebo in combination with trastuzumab and docetaxel as first line treatment in patients with HER2 positive metastatic breast cancer (PHILA): randomised, double blind, multicentre, phase 3 trial.
Ma F, Yan M, Li W, Ouyang Q, Tong Z, Teng Y, Wang Y, Wang S, Geng C, Luo T, Zhong J, Zhang Q, Liu Q, Zeng X, Sun T, Mo Q, Liu H, Cheng Y, Cheng J, Wang X, Nie J, Yang J, Wu X, Wang X, Li H, Ye C, Dong F, Wu S, Zhu X, Xu B; PHILA Investigators. Ma F, et al. Among authors: liu h. BMJ. 2023 Oct 31;383:e076065. doi: 10.1136/bmj-2023-076065. BMJ. 2023. PMID: 37907210 Free PMC article. Clinical Trial.
RNA-based translation activators for targeted gene upregulation.
Cao Y, Liu H, Lu SS, Jones KA, Govind AP, Jeyifous O, Simmons CQ, Tabatabaei N, Green WN, Holder JL Jr, Tahmasebi S, George AL Jr, Dickinson BC. Cao Y, et al. Among authors: liu h. Nat Commun. 2023 Oct 26;14(1):6827. doi: 10.1038/s41467-023-42252-z. Nat Commun. 2023. PMID: 37884512 Free PMC article.
Kinome-wide siRNA screen identifies a DCLK2-TBK1 oncogenic signaling axis in clear cell renal cell carcinoma.
Hu L, Zhang Y, Guo L, Zhong H, Xie L, Zhou J, Liao C, Yao H, Fang J, Liu H, Zhang C, Zhang H, Zhu X, Luo M, von Kriegsheim A, Li B, Luo W, Zhang X, Chen X, Mendell JT, Xu L, Kapur P, Baldwin AS, Brugarolas J, Zhang Q. Hu L, et al. Among authors: liu h. Mol Cell. 2024 Feb 15;84(4):776-790.e5. doi: 10.1016/j.molcel.2023.12.010. Epub 2024 Jan 10. Mol Cell. 2024. PMID: 38211588 Free PMC article.
98,983 results
You have reached the last available page of results. Please see the User Guide for more information.